Intramesosalpingeal injection of oxytocin in conservative laparoscopic treatment for tubal pregnancy

Preliminary results

Luigi Fedele, Stefano Bianchi, Luca Tozzi, Giovanni Zanconato, Vincenzo Silvestre

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The objective of this study was to evaluate the efficacy of the local use of oxytocin as adjuvant treatment in conservative surgery for tubal pregnancy. The patients were 25 women with laparoscopic diagnosis of tubal pregnancy who were candidates for salpingotomy. Before salpingotomy each patient was randomly allocated to intramesosalpingeal injection of 20 IU oxytocin diluted to 20 ml with saline solution or 20 ml saline solution. The surgeon then proceeded with salpingotomy and removal of the pregnancy according to the usual technique. The main outcome measures were bleeding during salpingotomy, ease of removal of the pregnancy, bleeding at the site of the pregnancy, and need for recourse to salpingectomy. Twelve women were randomized to the oxytocin group and 13 to the control group. Examination of the surgeons' assessments of the difficulties encountered at the different stages of surgery revealed statistically significant differences between the oxytocin group and controls in each variable. In particular, the amount of endosalpingeal bleeding after removal of the pregnancy was less in the oxytocin group. In one control patient, persistent bleeding due to incomplete trophoblast removal forced the surgeon to perform salpingectomy. Our results indicate that intramesosalpingeal injection of oxytocin facilitates the performance of conservative laparoscopic treatment for tubal pregnancy.

Original languageEnglish
Pages (from-to)3042-3044
Number of pages3
JournalHuman Reproduction
Volume13
Issue number11
Publication statusPublished - 1998

Fingerprint

Tubal Pregnancy
Oxytocin
Injections
Salpingectomy
Hemorrhage
Pregnancy
Sodium Chloride
Control Groups
Trophoblasts
Conservative Treatment
Outcome Assessment (Health Care)
Surgeons

Keywords

  • Ectopic pregnancy
  • Laparoscopy
  • Oxytocin

ASJC Scopus subject areas

  • Physiology
  • Developmental Biology
  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Intramesosalpingeal injection of oxytocin in conservative laparoscopic treatment for tubal pregnancy : Preliminary results. / Fedele, Luigi; Bianchi, Stefano; Tozzi, Luca; Zanconato, Giovanni; Silvestre, Vincenzo.

In: Human Reproduction, Vol. 13, No. 11, 1998, p. 3042-3044.

Research output: Contribution to journalArticle

Fedele, Luigi ; Bianchi, Stefano ; Tozzi, Luca ; Zanconato, Giovanni ; Silvestre, Vincenzo. / Intramesosalpingeal injection of oxytocin in conservative laparoscopic treatment for tubal pregnancy : Preliminary results. In: Human Reproduction. 1998 ; Vol. 13, No. 11. pp. 3042-3044.
@article{60a72646d0894265a22ebe0ef2f9662b,
title = "Intramesosalpingeal injection of oxytocin in conservative laparoscopic treatment for tubal pregnancy: Preliminary results",
abstract = "The objective of this study was to evaluate the efficacy of the local use of oxytocin as adjuvant treatment in conservative surgery for tubal pregnancy. The patients were 25 women with laparoscopic diagnosis of tubal pregnancy who were candidates for salpingotomy. Before salpingotomy each patient was randomly allocated to intramesosalpingeal injection of 20 IU oxytocin diluted to 20 ml with saline solution or 20 ml saline solution. The surgeon then proceeded with salpingotomy and removal of the pregnancy according to the usual technique. The main outcome measures were bleeding during salpingotomy, ease of removal of the pregnancy, bleeding at the site of the pregnancy, and need for recourse to salpingectomy. Twelve women were randomized to the oxytocin group and 13 to the control group. Examination of the surgeons' assessments of the difficulties encountered at the different stages of surgery revealed statistically significant differences between the oxytocin group and controls in each variable. In particular, the amount of endosalpingeal bleeding after removal of the pregnancy was less in the oxytocin group. In one control patient, persistent bleeding due to incomplete trophoblast removal forced the surgeon to perform salpingectomy. Our results indicate that intramesosalpingeal injection of oxytocin facilitates the performance of conservative laparoscopic treatment for tubal pregnancy.",
keywords = "Ectopic pregnancy, Laparoscopy, Oxytocin",
author = "Luigi Fedele and Stefano Bianchi and Luca Tozzi and Giovanni Zanconato and Vincenzo Silvestre",
year = "1998",
language = "English",
volume = "13",
pages = "3042--3044",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Intramesosalpingeal injection of oxytocin in conservative laparoscopic treatment for tubal pregnancy

T2 - Preliminary results

AU - Fedele, Luigi

AU - Bianchi, Stefano

AU - Tozzi, Luca

AU - Zanconato, Giovanni

AU - Silvestre, Vincenzo

PY - 1998

Y1 - 1998

N2 - The objective of this study was to evaluate the efficacy of the local use of oxytocin as adjuvant treatment in conservative surgery for tubal pregnancy. The patients were 25 women with laparoscopic diagnosis of tubal pregnancy who were candidates for salpingotomy. Before salpingotomy each patient was randomly allocated to intramesosalpingeal injection of 20 IU oxytocin diluted to 20 ml with saline solution or 20 ml saline solution. The surgeon then proceeded with salpingotomy and removal of the pregnancy according to the usual technique. The main outcome measures were bleeding during salpingotomy, ease of removal of the pregnancy, bleeding at the site of the pregnancy, and need for recourse to salpingectomy. Twelve women were randomized to the oxytocin group and 13 to the control group. Examination of the surgeons' assessments of the difficulties encountered at the different stages of surgery revealed statistically significant differences between the oxytocin group and controls in each variable. In particular, the amount of endosalpingeal bleeding after removal of the pregnancy was less in the oxytocin group. In one control patient, persistent bleeding due to incomplete trophoblast removal forced the surgeon to perform salpingectomy. Our results indicate that intramesosalpingeal injection of oxytocin facilitates the performance of conservative laparoscopic treatment for tubal pregnancy.

AB - The objective of this study was to evaluate the efficacy of the local use of oxytocin as adjuvant treatment in conservative surgery for tubal pregnancy. The patients were 25 women with laparoscopic diagnosis of tubal pregnancy who were candidates for salpingotomy. Before salpingotomy each patient was randomly allocated to intramesosalpingeal injection of 20 IU oxytocin diluted to 20 ml with saline solution or 20 ml saline solution. The surgeon then proceeded with salpingotomy and removal of the pregnancy according to the usual technique. The main outcome measures were bleeding during salpingotomy, ease of removal of the pregnancy, bleeding at the site of the pregnancy, and need for recourse to salpingectomy. Twelve women were randomized to the oxytocin group and 13 to the control group. Examination of the surgeons' assessments of the difficulties encountered at the different stages of surgery revealed statistically significant differences between the oxytocin group and controls in each variable. In particular, the amount of endosalpingeal bleeding after removal of the pregnancy was less in the oxytocin group. In one control patient, persistent bleeding due to incomplete trophoblast removal forced the surgeon to perform salpingectomy. Our results indicate that intramesosalpingeal injection of oxytocin facilitates the performance of conservative laparoscopic treatment for tubal pregnancy.

KW - Ectopic pregnancy

KW - Laparoscopy

KW - Oxytocin

UR - http://www.scopus.com/inward/record.url?scp=0031783273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031783273&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 3042

EP - 3044

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 11

ER -